The SGPL1 gene helps your body break down sphingosine 1-phosphate, a fatty signal that helps control how cells grow, move, and survive. This gene plays an important role in keeping the kidneys, adrenal glands, immune system, nerves, and skin in balance. If the SGPL1 gene does not work properly, this signal can build up and disrupt several organs. People with harmful variants in both copies of this gene can develop a rare inherited condition with kidney disease, hormone problems, skin changes, and other symptoms.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the information needed to make proteins, which are the parts of cells that do the work. Others mainly help determine when certain processes happen, where they happen, and how strongly they operate. Taken together, genes influence the body’s development and function, and they can shape how you respond to food, stress, or medications. More on this topic is available in the LearnHub.
Overview
SGPL1Gene function
What if the gene works
The SGPL1 gene helps cells break down sphingosine 1 phosphate, a signaling fat. This helps control cell growth, immune cell movement, and fat balance in tissues.
Risk
What if the gene does not work
Variants in the SGPL1 gene can cause a condition that affects the kidneys and adrenal glands, and may also involve the skin, nerves, or immunity. Milder and severe variants can influence when features appear and how extensive they are.
Treatment
What does that mean for your treatment
No SGPL1-specific treatment or drug-selection approach is currently established in clinical guidelines. Care is symptom-based, and research is exploring ways to lower sphingolipid buildup or restore SGPL1 activity, but these approaches remain experimental.
Conditions associated with SGPL1
Gene function
What if the gene works
Your cells use the SGPL1 gene to keep certain fats at the right level from moment to moment. It helps break down sphingosine-1-phosphate (a signaling fat used by cells), which supports steady communication inside the body and normal fat recycling. Understanding what the SGPL1 gene does helps make sense of how cells keep their internal balance.
The SGPL1 gene helps cells break down sphingosine-1-phosphate (a signaling fat used by cells). This is an important cleanup step in normal sphingolipid turnover, which means old or extra fats can be processed instead of building up.
By lowering sphingosine-1-phosphate after it has done its job, this gene helps keep cell signaling in balance. That steady control supports routine processes such as growth, movement, and cell survival.
The protein from the SGPL1 gene splits this signaling fat into smaller parts that cells can reuse. Those parts feed into normal lipid handling and other everyday cell processes.
Because signaling fats need tight control, SGPL1 activity helps cells keep their internal environment steady. This kind of balance, called homeostasis (stable day to day conditions), supports normal cell function.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SGPL1 gene can make the SGPL1 protein unstable, misfolded, or shortened, which often reduces or abolishes enzyme activity and disrupts the breakdown of sphingosine 1-phosphate, a signaling molecule. This can build up inside cells and alter survival and stress-response pathways. How SGPL1 gene variants affect function varies: milder variants may leave some activity, while more severe variants can cause little or none. That difference may influence how early SGPL1 deficiency appears and the range of features seen.
How variants are linked to conditions
Pathogenic variants in the SGPL1 gene cause sphingosine phosphate lyase insufficiency syndrome (SPLIS), a rare inherited condition and the main condition linked to SGPL1 gene variants. It is most often associated with kidney disease, especially steroid resistant nephrotic syndrome, and adrenal hormone problems. Some people also have skin changes, nerve or developmental concerns, immune problems, or slower growth.
A variant is not necessarily a diagnosis
Variants in genes are a normal feature of human biology and are widely seen across the population. Most do not directly affect health and instead represent ordinary human variation. For many genes, having a variant associated with a condition points to a possible link, not a confirmed diagnosis, particularly when several genes and environmental influences play a role. Still, in certain situations, one well understood variant in a particular gene is enough to establish a diagnosis.
Are there things that can increase or change my risk?
For SGPL1, risk is mainly shaped by genetics: a child is affected when they inherit disease-causing changes in both copies of the gene, usually one from each parent. There is not broadly confirmed evidence that lifestyle or environmental factors meaningfully increase or reduce this gene-related risk.
Inheritance of SGPL1 variants
SGPL1-related conditions are usually inherited in an autosomal recessive pattern. In practical terms, inheritance of the SGPL1 gene variants typically means a child has to receive one altered copy from each parent to be affected. Parents who each carry one SGPL1 variant are usually unaffected themselves, and with each pregnancy there is a 25% chance the child will inherit both altered copies, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither altered copy. This pattern applies equally to boys and girls.
What does my SGPL1 result mean for my family?
For SGPL1, family implications usually follow a recessive pattern. Parents of an affected child are often healthy carriers, and brothers or sisters may also be affected or may be carriers. Other blood relatives, such as aunts, uncles, and cousins, can sometimes carry the same gene change too.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the SGPL1 gene, doctors use genetic testing for SGPL1 variants on a blood or saliva sample. The lab reads the gene’s DNA sequence to look for variants and may test SGPL1 alone or include it in a broader panel. Results may show a variant, no variant, or a finding with uncertain meaning.
When should I consider getting a genetic test?
Consider SGPL1 testing when a child has a mix of early kidney disease, very low adrenal hormone levels, skin changes, nerve problems, or delayed development, especially if similar problems run in the family. Testing can help confirm whether SGPL1 is the cause.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and on the type of variant involved. Factors such as lifestyle, environment, age, and medical history also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, these results can help make individual experiences easier to understand.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles some medicines. Small differences in DNA can change how a drug is absorbed, broken down, moved through the body, or how strongly it acts on its target. This helps explain why the same treatment may work well for one person, seem weaker in another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect their response to medications. It studies gene and drug patterns to help explain why the same treatment may work differently from one person to another. With many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the SGPL1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used. Questions about side effects, new symptoms, or how a treatment is working are best discussed with your doctor or pharmacist.
History
The SGPL1 gene entered medical genetics more recently than many better known genes. In recent decades, awareness of this gene’s role has grown as researchers connected sphingolipid biology with rare inherited conditions. Early laboratory work identified the gene as part of a pathway that helps break down signaling fats, and animal studies showed that losing this activity could strongly affect development and organ health. Building on this early work, scientists later linked harmful SGPL1 variants to a multisystem condition now called sphingosine phosphate lyase insufficiency syndrome, or SPLIS. That discovery helped explain why some children had a combination of kidney, adrenal, skin, nerve, and growth problems that had previously been difficult to tie together. Since then, the gene has become an important part of research on rare metabolic and endocrine conditions.